Example: Heart Attack

Search clinical trials for: Alprazolam

Total 86 results

NCT00878865

Completed

Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets

Conditions: Healthy
NCT01188031

Completed

A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting Conditions

Conditions: Healthy
NCT01188057

Completed

A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting Conditions

Conditions: Healthy
NCT04715269

Recruiting

Role of Alprazolam in the Management of Acute Coronary Syndrome

Conditions: Acute Coronary Syndrome; Myocardial Infarction; ST Elevation Myocardial Infarction; Heart Diseases; Anxiety
NCT00878514

Completed

Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions

Conditions: Healthy
NCT01256151

Completed

Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet

Conditions: Anxiety Disorder
NCT03702803

Recruiting

Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety.

Conditions: Generalized Anxiety Disorder
NCT00860119

Completed

Bioequivalence of Alprazolam Sublingual vs Oral Tablets

Conditions: Healthy
NCT01027689

Withdrawn

Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation

Conditions: Healthy
NCT00829426

Completed

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting Conditions

Conditions: Healthy
NCT00634790

Terminated

A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks

Conditions: Panic Disorder
NCT00830024

Completed

Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting Conditions

Conditions: Healthy
NCT03516305

Completed

Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers

Conditions: Healthy
NCT00865761

Completed

A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions

Conditions: Healthy
NCT00865657

Completed

A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions

Conditions: Healthy
NCT01546090

Completed

Effect of Alprazolam on the Success of Inferior Alveolar Nerve (IAN) Block

Conditions: Inferior Alveolar Nerve Block Failure
NCT00803400

Completed

Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder Treatment

Conditions: Panic Disorder
NCT01046162

Withdrawn

A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions

Conditions: Healthy
NCT00703885

Completed

PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)

Conditions: Anxiety Disorders
NCT04658732

Recruiting

A Comparative Study of Oral Gabapentin, Oral Alprazolam and Intravenous Dexmedetomidine on Perioperative Anxiety and Pain During Posterior Segment Eye Surgery Under Peribulbar Block : a Randomized, Double-blind Study.

Conditions: Sedation for Patients Undergoing Peribulbar Block
NCT00635531

Terminated

A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder

Conditions: Panic Disorder
NCT00635076

Terminated

A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder

Conditions: Panic Disorder
NCT01285505

Withdrawn

Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation

Conditions: Healthy
NCT03130842

Completed

Premedication With Alprazolam and Midazolam for Upper Gastrointestinal Endoscopy

Conditions: Diagnostic Esophagogastroduodenoscopy
NCT00877955

Withdrawn

Bioequivalence Of A Test Alprazolam Sublingual Formulation Compared To A Commercial Sublingual Formulation

Conditions: Healthy